Upakaar is live now for Order.

Clarify 250

Clarify 250 Tablet is an antibiotic manufactured by Sumy Pharmaceuticals Pvt. Ltd. in Nepal. Its active ingredient is Clarithromycin 250mg. It’s also available as a 500mg tablet and in other forms under different brand names.

Ask about product

Description

Clarify 250 is used to treat a variety of bacterial infections, including:

  • Respiratory tract infections: Such as pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, and pneumonia (including community-acquired pneumonia and legionellosis).
  • Skin and soft tissue infections.
  • Leprosy.
  • Peptic ulcer disease: Especially when caused by Helicobacter pylori. It’s typically used as part of a multi-drug regimen.
  • Lyme disease.
  • Acne.

 

How Do You Take It?

 

Dosage varies based on the infection and patient age. Always follow your doctor’s instructions precisely.

 

Adult Dosing (Oral)

 

  • Acute Exacerbation of Chronic Bronchitis: 250-500 mg every 12 hours for 7-14 days. Extended-release (XL) may be 1000 mg once daily for 7 days.
  • Mycobacterial Infection (Prophylaxis and Treatment): 500 mg every 12 hours for 7-14 days, usually with other antimycobacterial drugs.
  • Peptic Ulcer Disease: 500 mg every 8-12 hours for 10-14 days, as part of a 2 or 3-drug combination.
  • Pharyngitis, Tonsillitis: 250 mg every 12 hours for 10 days.
  • Community-Acquired Pneumonia, Skin/Skin Structure Infection: 250 mg every 12 hours for 7-14 days. XL may be 1000 mg once daily for 7 days.
  • Endocarditis Prophylaxis: 500 mg 30-60 minutes before a surgical procedure.

 

Adult Dosing (Intravenous)

 

  • Respiratory tract infections, Skin and soft tissue infections, Susceptible infections: 500 mg twice daily for 2-5 days, infused over 60 minutes. Oral therapy should be started as soon as possible.

Additional information

form

PACK

Reviews

There are no reviews yet.

Be the first to review “Clarify 250”

Your email address will not be published. Required fields are marked *